Urine phthalate metabolites are associated with urothelial cancer in chronic kidney disease patients
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Chemosphere
- Vol. 273, 127834
Abstract
No abstract availableKeywords
Funding Information
- Academia Sinica (BI 10150264, BM102021124, BM103010089, BM104010113)
- Department of Health
This publication has 20 references indexed in Scilit:
- Development and validation of a nomogram for urothelial cancer in patients with chronic kidney diseaseScientific Reports, 2019
- Association between urinary phthalate metabolites and risk of breast cancer and uterine leiomyomaReproductive Toxicology, 2017
- Phthalate exposure, flavonoid consumption and breast cancer risk among Mexican womenEnvironment International, 2016
- CKD and the Risk of Incident CancerJournal of the American Society of Nephrology, 2014
- Tumour Markers and Kidney Function: A Systematic ReviewBioMed Research International, 2014
- Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in TaiwanPLOS ONE, 2012
- Exposure to Phthalates and Breast Cancer Risk in Northern MexicoEnvironmental Health Perspectives, 2010
- Alcohol Consumption and the Prevalence of the Metabolic Syndrome in the U.S.Diabetes Care, 2004
- Effects of Di-2-Ethylhexyl Phthalate (DEHP) on Gap-Junctional Intercellular Communication (GJIC), DNA Synthesis, and Peroxisomal Beta Oxidation (PBOX) in Rat, Mouse, and Hamster LiverToxicological Sciences, 2000
- The carcinogenicity of dietary di(2‐ethylhexyl) phthalate (DEHP) in fischer 344 rats and B6C3F1miceJournal of Toxicology and Environmental Health, 1982